1 to 10 of 44 literature results

• Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

  A major goal of immunotherapy for autoimmune diseases and transplantation is induction of regulatory T cells that mediate immunologic tolerance. The m…

  Authors: Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, Dan Frenkel, Kaiyong Yang, Alexandre S Basso, Henry Wu, Mei-Ling Chen, Roopali Gandhi, Ariel Miller,…

  Source: Nature medicine. 2006 Jun

  View Full Text

• Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect.

  The purpose of this study was to characterize the brain activity and associated cortical structures involved in pseudobulbar affect (PBA), a condition…

  Authors: Guy Haiman, Hillel Pratt, Ariel Miller

  Source: Journal of clinical psychopharmacology. 2009 Oct

  View Full Text

• Impact of exposure to war stress on exacerbations of multiple sclerosis.

  OBJECTIVE: To assess the relation between stress caused by the perils of rocket attack on civilian centers in northern Israel during the 2006 war betw…

  Authors: Daniel Golan, Eli Somer, Sara Dishon, Limor Cuzin-Disegni, Ariel Miller

  Source: Annals of neurology. 2008 Aug

  View Full Text

• Virtual reality cues for improvement of gait in patients with multiple sclerosis.

  OBJECTIVE: To study the effects of visual cues, provided through a portable visual-feedback virtual reality (VR) apparatus, on the walking abilities o…

  Authors: Yoram Baram, Ariel Miller

  Source: Neurology. 2006 Jan 24

  View Full Text

• Multiple sclerosis frequency in Israel's diverse populations.

  BACKGROUND: Israel has served for almost half a century as a site for epidemiologic studies of multiple sclerosis (MS). Its small geographic size, wel…

  Authors: Milton Alter, Esther Kahana, Nelly Zilber, Ariel Miller

  Source: Neurology. 2006 Apr 11

  View Full Text

• Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.

  Pseudobulbar affect (PBA), a condition involving involuntary and uncontrollable episodes of crying and/or laughing, occurs frequently in patients with…

  Authors: Ariel Miller

  Source: Journal of the neurological sciences. 2006 Jun 15

  View Full Text

• Emerging therapeutic targets in multiple sclerosis.

  PURPOSE OF REVIEW: The aim of this review is to describe the recent findings regarding the pathogenesis of multiple sclerosis and their translation to…

  Authors: Paulo Fontoura, Lawrence Steinman, Ariel Miller

  Source: Current opinion in neurology. 2006 Jun

  View Full Text

• Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses.

  This study compares the effects of daytime versus nighttime intravenous glucocorticoid treatment of multiple sclerosis (MS) relapses for several immun…

  Authors: Lea Glass-Marmor, Tamar Paperna, Yanna Galboiz, Ariel Miller

  Source: Journal of neuroimmunology. 2009 May 29

  View Full Text

• Auditory feedback control for improvement of gait in patients with Multiple Sclerosis.

  OBJECTIVE: To study the use of auditory feedback for gait management and rehabilitation in patients with Multiple Sclerosis (MS). METHODS: An auditory…

  Authors: Yoram Baram, Ariel Miller

  Source: Journal of the neurological sciences. 2007 Mar 15

  View Full Text

• Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.

  A variety of neurological conditions and disease states are accompanied by pseudobulbar affect (PBA), an emotional disorder characterized by uncontrol…

  Authors: Ariel Miller, Hillel Panitch

  Source: Journal of the neurological sciences. 2007 Aug 15

  View Full Text